Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials

Questions remain regarding the effect of baseline host and exposure factors on vaccine efficacy (VE) across pathogens and vaccine platforms. We report placebo-controlled data from four Phase 3 COVID-19 trials during the early period of the pandemic. This was a cross-protocol analysis of four randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Turley, Christine B., Tables, LaKesha, Fuller, Trevon, Sanders, Lisa J., Scott, Hyman, Moodley, Amaran, Woodward Davis, Amanda, Leav, Brett, Miller, Jacqueline, Schoemaker, Kathryn, Vandebosch, An, Sadoff, Jerald, Woo, Wayne, Cho, Iksung, Dunkle, Lisa M., Li, Sijia, van der Laan, Lars, Gilbert, Peter B., Follmann, Dean, Jaynes, Holly, Kublin, James G., Baden, Lindsey R., Goepfert, Paul, Kotloff, Karen, Gay, Cynthia L., Falsey, Ann R., El Sahly, Hana M., Sobieszczyk, Magdalena E., Huang, Yunda, Neuzil, Kathleen M., Corey, Lawrence, Grinsztejn, Beatriz, Gray, Glenda, Rouphael, Nadine, Luedtke, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288314/
https://www.ncbi.nlm.nih.gov/pubmed/37385888
http://dx.doi.org/10.1016/j.vaccine.2023.06.066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288314/
https://www.ncbi.nlm.nih.gov/pubmed/37385888
http://dx.doi.org/10.1016/j.vaccine.2023.06.066

Ejemplares similares